• No results found

New insight into device therapy for chronic heart failure Ypenburg, C.

N/A
N/A
Protected

Academic year: 2021

Share "New insight into device therapy for chronic heart failure Ypenburg, C."

Copied!
3
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

New insight into device therapy for chronic heart failure

Ypenburg, C.

Citation

Ypenburg, C. (2008, October 30). New insight into device therapy for chronic heart failure. Retrieved from https://hdl.handle.net/1887/13210

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/13210

Note: To cite this publication please use the final published version (if applicable).

(2)

Part I

ISSUES BEFORE DEVICE IMPLANTATION

(3)

Referenties

GERELATEERDE DOCUMENTEN

Echocardiography including speckle tracking strain analysis was performed at baseline, after CRT initiation and during interruption of CRT at 6 months of follow-up to study

The results of the current study can be summarized as follows: 1) the majority of patients included in this study improved in MR after CRT, with 43% improving immediately after CRT,

Secondary prevention patients were more likely to have ischemic heart disease, more previous myocardial infarctions, more ventricular arrhythmias and a higher amiodarone usage:

Furthermore, an audible alarm (OptiVol alert) can be triggered when a decrease in intrathoracic impedance indicates pulmonary fluid accumulation secondary to left-sided heart

Reduced ventricular volumes and improved systolic function with cardiac resynchronization therapy: a randomized trial comparing simultaneous biventricular pacing,

All patients underwent echocardiography including 2D speckle tracking radial strain analysis at baseline, immediate after implant, at 6 months follow-up and during interruption,

Tri-plane tissue Doppler imaging: a novel 3-dimensional imaging modality that predicts reverse left ventricular remodeling after cardiac resynchronization therapy.. van

Peripheral blood cells were stained with HLA-A2.1 tetramers containing the tyrosinase368–376 peptide followed by staining with a panel of lineage antibodies, as described in